The number of individuals who are obese or overweight has dramatically increased over recent years and is now becoming epidemic.These individuals are more likely to suffer cardiovascular diseases and therefore physicians, specialists and trainees increasingly need to deal with these issues on the ward and in clinic. As a result, the need for appropriate knowledge of up-to-date clinical management of obesity and its associated cardiovascular problems is essential for any practising physician.

Obesity and Cardiovascular Disease is a readily assimilated pocket guide to obesity and cardiovascular disease. It is intended to be used 'on-the-go' and is compact enough to be on hand whilst in consultation with patients. It provides a clear and succinct overview of contemporary clinical management of cardiovascular risk stratification, and fully covers the diagnosis and treatment of cardiovascular in obese patients and individuals with increased visceral adiposity, translating up-to-date clinical research findings into clinical practice. Particular emphasis is placed on recent updates in practical care in obesity and cardiovascular disease, such as new diagnostic techniques and novel pharmacological and surgical approaches, as well as cardiac visceral fat, ethnic differences in adiposity-related cardiovascular risk, and metabolically healthy, but obese subjects. Topics are presented in an easily accessible format with numerous illustrations, photographs, tables, diagnostic and therapeutic algorithms while highlight boxes summarise the main concepts discussed in each chapter.

Gianluca Iacobellis' profile page

Gianluca Iacobellis obtained his Medical Doctor (MD) degree in 1994 from the University of Roma, La Sapienza, Italy. He became Post Doctoral Clinical Research Fellow at the Center for Human Nutrition Southwestern Medical Center, Dallas, USA from 2004 to 2005 and was Clinical Research Fellow in the Cardiovascular Obesity Research and Management and Bariatric Clinic Hamilton Health Sciences, McMaster University, Hamilton, Canada from 2005 to 2006. He has authored and co-authored more than 60 peer-reviewed papers and 10 textbooks. His research and clinical interest is mainly focused on the cardiovascular risk in obesity and metabolic syndrome. He pioneered and developed the echocardiographic epicardial fat quantification, as a practical and reliable marker of visceral adiposity and therapeutic target. He lectures widely on obesity and cardiovascular disease and is currently principal investigator and co-investigator of several clinical trials.